Becton Dickinson
Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.
Becton Dickinson Q4 Revenues Grow 7 Percent
Revenues for BD's Life Sciences segment, which includes the Integrated Diagnostic Solutions and Biosciences business units, were up 1 percent to $1.34 billion.
Becton Dickinson Gets Health Canada Approval for HPV Test With Self-Collected Samples
The firm said that the updated approval will improve access to HPV testing by providing a less invasive and less expensive alternative to Pap tests.
In Brief This Week: ADLM, Labcorp, Foresight Diagnostics, T2 Biosystems, More
News items for the week of Oct. 7, 2024.
Becton Dickinson Fiscal Q3 Revenues Rise 2 Percent
The Franklin Lakes, New Jersey-based firm lowered the upper limit of its full-year revenue guidance and raised the lower limit of its EPS projection.